Itacitinib is an inhibitor of JAK1.1 It is greater than 20- and 200-fold selective for JAK1 over JAK2 and JAK3, respectively.
1.Norman, P.Selective JAK inhibitors in development for rheumatoid arthritisExpert Opin. Investig. Drugs23(8)1067-1077(2014)
















